Concepts (69)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parents | 6 | 2025 | 375 | 2.640 |
Why?
|
| Neoplasms | 7 | 2025 | 1324 | 2.480 |
Why?
|
| Anxiety | 5 | 2025 | 415 | 1.030 |
Why?
|
| Nurses, Pediatric | 1 | 2025 | 6 | 0.940 |
Why?
|
| Oncology Nursing | 1 | 2025 | 16 | 0.930 |
Why?
|
| Nurse Clinicians | 1 | 2024 | 12 | 0.880 |
Why?
|
| Depression | 4 | 2025 | 863 | 0.870 |
Why?
|
| Health Services Needs and Demand | 1 | 2025 | 206 | 0.860 |
Why?
|
| Burkitt Lymphoma | 1 | 2023 | 57 | 0.810 |
Why?
|
| Stress, Psychological | 6 | 2025 | 461 | 0.770 |
Why?
|
| Poverty | 1 | 2024 | 295 | 0.760 |
Why?
|
| Qualitative Research | 5 | 2025 | 657 | 0.730 |
Why?
|
| Attitude of Health Personnel | 2 | 2025 | 578 | 0.720 |
Why?
|
| Dyspnea | 4 | 2025 | 121 | 0.720 |
Why?
|
| Child | 8 | 2025 | 4366 | 0.670 |
Why?
|
| Lung Neoplasms | 4 | 2025 | 636 | 0.590 |
Why?
|
| Lymphoma, Extranodal NK-T-Cell | 2 | 2025 | 3 | 0.480 |
Why?
|
| Grounded Theory | 2 | 2025 | 18 | 0.480 |
Why?
|
| Lymphoma, T-Cell | 2 | 2025 | 23 | 0.480 |
Why?
|
| Focus Groups | 3 | 2025 | 297 | 0.470 |
Why?
|
| Adult | 11 | 2025 | 16361 | 0.460 |
Why?
|
| Behavior Therapy | 2 | 2025 | 165 | 0.420 |
Why?
|
| Male | 14 | 2025 | 28947 | 0.400 |
Why?
|
| Female | 14 | 2025 | 31953 | 0.380 |
Why?
|
| Humans | 18 | 2025 | 61707 | 0.340 |
Why?
|
| Cross-Sectional Studies | 3 | 2025 | 2491 | 0.320 |
Why?
|
| Middle Aged | 10 | 2025 | 17079 | 0.290 |
Why?
|
| Terminal Care | 2 | 2025 | 103 | 0.270 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2025 | 72 | 0.270 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2025 | 136 | 0.260 |
Why?
|
| Adolescent | 3 | 2025 | 6060 | 0.250 |
Why?
|
| Child, Preschool | 3 | 2025 | 1891 | 0.240 |
Why?
|
| Quality of Life | 4 | 2025 | 1206 | 0.240 |
Why?
|
| Palliative Care | 2 | 2024 | 224 | 0.240 |
Why?
|
| Uncertainty | 1 | 2025 | 34 | 0.240 |
Why?
|
| Nurse's Role | 1 | 2025 | 120 | 0.230 |
Why?
|
| Resilience, Psychological | 1 | 2025 | 60 | 0.220 |
Why?
|
| Needs Assessment | 1 | 2025 | 195 | 0.220 |
Why?
|
| Nigeria | 1 | 2023 | 9 | 0.220 |
Why?
|
| Housing | 1 | 2024 | 73 | 0.220 |
Why?
|
| Education, Nursing, Baccalaureate | 1 | 2024 | 39 | 0.220 |
Why?
|
| Prognosis | 2 | 2025 | 1687 | 0.210 |
Why?
|
| Adaptation, Psychological | 1 | 2025 | 262 | 0.210 |
Why?
|
| Income | 1 | 2024 | 166 | 0.210 |
Why?
|
| Pandemics | 2 | 2025 | 655 | 0.210 |
Why?
|
| Nurses | 1 | 2024 | 103 | 0.210 |
Why?
|
| Students, Nursing | 1 | 2024 | 74 | 0.200 |
Why?
|
| Aged | 7 | 2025 | 14043 | 0.190 |
Why?
|
| Social Media | 1 | 2024 | 122 | 0.190 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2025 | 427 | 0.180 |
Why?
|
| Vaccination | 1 | 2024 | 347 | 0.180 |
Why?
|
| Aged, 80 and over | 3 | 2025 | 5334 | 0.180 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 713 | 0.170 |
Why?
|
| Surveys and Questionnaires | 2 | 2025 | 2616 | 0.170 |
Why?
|
| Prevalence | 1 | 2024 | 1329 | 0.170 |
Why?
|
| Follow-Up Studies | 1 | 2025 | 2418 | 0.160 |
Why?
|
| Prospective Studies | 1 | 2025 | 3216 | 0.140 |
Why?
|
| Recurrence | 2 | 2025 | 626 | 0.100 |
Why?
|
| United States | 1 | 2025 | 7622 | 0.100 |
Why?
|
| Professional-Family Relations | 1 | 2025 | 88 | 0.060 |
Why?
|
| Self Efficacy | 1 | 2025 | 194 | 0.060 |
Why?
|
| Morphine | 1 | 2024 | 51 | 0.050 |
Why?
|
| Neoplasm Staging | 1 | 2024 | 473 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 2025 | 6399 | 0.050 |
Why?
|
| Self Report | 1 | 2024 | 364 | 0.050 |
Why?
|
| Infant | 1 | 2025 | 1553 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2025 | 1523 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2025 | 5497 | 0.030 |
Why?
|
| Young Adult | 1 | 2024 | 4538 | 0.030 |
Why?
|